Regeneron Pharmaceuticals Inc. (REGN): Price and Financial Metrics
REGN Price/Volume Stats
| Current price | $758.29 | 52-week high | $1,211.20 |
| Prev. close | $762.34 | 52-week low | $735.95 |
| Day low | $753.65 | Volume | 131,848 |
| Day high | $770.00 | Avg. volume | 542,723 |
| 50-day MA | $899.07 | Dividend yield | N/A |
| 200-day MA | $995.78 | Market Cap | 83.33B |
REGN Stock Price Chart Interactive Chart >
Regeneron Pharmaceuticals Inc. (REGN) Company Bio
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors. (Wikipedia:Source)
REGN Price Returns
| 1-mo | -10.11% |
| 3-mo | -35.70% |
| 6-mo | -24.23% |
| 1-year | -7.90% |
| 3-year | 19.39% |
| 5-year | 105.87% |
| YTD | -13.66% |
| 2023 | 21.73% |
| 2022 | 14.25% |
| 2021 | 30.72% |
| 2020 | 28.66% |
| 2019 | 0.53% |
Continue Researching REGN
Want to see what other sources are saying about Regeneron Pharmaceuticals Inc's financials and stock price? Try the links below:Regeneron Pharmaceuticals Inc (REGN) Stock Price | Nasdaq
Regeneron Pharmaceuticals Inc (REGN) Stock Quote, History and News - Yahoo Finance
Regeneron Pharmaceuticals Inc (REGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...